Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Affluent Medical S.A. is a medical technology company dedicated to the development of innovative healthcare solutions. With a focus on urology and interventional cardiology, the company is at the forefront of creating next-generation implants specifically designed to improve patients’ quality of life. Affluent Medical’s portfolio includes products such as artificial urinary sphincters and devices aimed at treating mitral valve insufficiency. By leveraging its expertise in minimally invasive techniques, the company addresses significant unmet medical needs, impacting healthcare sectors by providing advanced solutions for chronic conditions. Headquartered in France, Affluent Medical positions itself in the highly dynamic global medtech industry, contributing to significant advancements in patient care through its continuous research and development efforts.
The business is unprofitable at the operating level (-355.44% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Negative free cash flow of -€11M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
€4M
Net Income (TTM)
-€15M
▲ +5.8% YoY
Op. Margin
-355.44%
ROIC
-24.35%
Cash Flow & Balance Sheet
FCF (TTM)
-€11M
▲ +6.3% YoY
Op. Cash Flow (TTM)
-€11M
▲ +6.2% YoY
Net Debt
€10M
Cash & Equiv.
€7M
Continue Research